Abstract
The field of immunology is principally focused on the molecular mechanisms by which hematopoetic cells initiate and maintain innate and adaptive immunity. That cornerstone of attention has been expanded by recent discoveries that neuronal signals occupy a critical regulatory niche in immunity. The discovery is that neuronal circuits operating reflexively regulate innate and adaptive immunity. One particularly well-characterized circuit regulating innate immunity, the inflammatory reflex, is dependent upon action potentials transmitted to the reticuloendothelial system via the vagus and splenic nerves. This field has grown significantly with identification of several other reflexes regulating discrete immune functions. As reviewed here, the delineation of these mechanisms revealed a new understanding of immunity, enabled a first in class clinical trial using bioelectronic devices to inhibit cytokines and inflammation in rheumatoid arthritis patients, and provided a mosaic view of immunity as the integration of hematopoetic and neural responses to infection and injury.
The history of immunology is a rich story of insights that originated with clinical observations, advanced through technological innovation, and culminated by identification of cellular and molecular mechanisms. Exploiting advances from other fields of science has accelerated progress in immunology, be it growing pathogens in pure cultures, isolating pathogenic toxins and antigens, visualizing phagocytosis and cell-mediated killing, or mass-producing monoclonal antibodies and cytokines. Most of this work has been focused on hematopoetic cells, and the organs that they inhabit, the reticuloendothelial system. The products of immunology research are new therapies that benefit millions, including treating autoimmune diseases with monoclonal antibodies, and treating cancer with modified T cells and check point inhibitors. Today, by exploiting advances in neuroscience, there is a major new opportunity for immunologists to discover new mechanisms in immunity and accelerate efforts to develop new therapeutic solutions.
What happened in neuroscience to enable this possibility? A basic answer is the discovery that neurons are integral components of the immune system, and that a full understanding of immunity requires understanding the role of reflex neural circuits that regulate hematopoetic cells. Sensory neurons are present on the front line of host defense, and like macrophages, other phagocytes, and antigen presenting cells, these neurons interact directly with the inflammatory products of pathogens and host. This interaction initiates sensory neuronal action potentials that are conveyed into the nervous system within milliseconds of the onset of invasion or inflammation. This action potential signaling mechanism is several orders of magnitude faster than can be accomplished by immune cell release of cytokines and other mediators. Information returning from the nervous system to the reticuloendothelial system reflexively regulates the activity of innate and adaptive immune responses. Recent discoveries have revealed the molecular mechanisms for the neural control of cytokine production, chemotaxis, germinal center formation, antigen presentation, and other fundamental aspects of immunity.
Considering that it has been known for decades that neurons reside within a few micrometers of virtually every cell in the reticuloendothelial system, and within the epithelial system at the front line of host defense, and that neurotransmitters modulate hematopoetic cell functions, it may be appropriate to wonder why neurons had not previously been considered to be an integral component of the immune system? Accordingly, herein we review recent advances in neuroscience and immunology that have revealed the fundamental importance of reflex neural circuits to understanding immunity. A brief overview of the fundamental physiology of reflex circuits precedes a summary of several specific examples of reflex mechanisms in immunity. These are presented as a gentle argument that future students of immunology may be able to advance the field further by continuing to blur the lines between the fields of neuroscience and immunology, in order to completely understand immunity.
Reflexes maintain health in organ systems
A neural reflex is defined by three components: first a sensory receptor capable of responding to a change in the environment; second a sensory or afferent arc that transmits action potentials into the nervous system; third a motor or efferent arc that sends action potentials from the nervous system back to the periphery to modulate the environment. Charles Sherrington, one of the fathers of neuroscience, proposed that this basic unit of reflex action provides a fundamental building block upon which an entire nervous system can be assembled (1, 2). Reflexes function at the speed of action potentials, which is sufficient to control the output of organ systems nearly instantaneously. The cardiovascular, gastrointestinal, respiratory, hepatobiliary, and renal organ systems are all regulated by reflexes that respond to changes in the internal milieu and send corrective and compensatory signals to maintain homeostasis. Reflex integration of physiological output has evolutionarily ancient origins, dating back to C. elegans, a nematode with 302 neurons and a rudimentary immune system (3). Reflexes in mammals and vertebrates evolved to exquisitely maintain organ homeostasis despite a wide range of environmental variability and threat.
One example that perhaps best illustrates the function of a simple reflex controlling the output of a complex system can be found in the neural control of heart rate. The principle sensory nerve to the visceral organs, including the heart and reticuloendothelial system, is the vagus nerve. It is a paired structure, arising in the brain stem that descends through the thorax and abdomen to innervate the visceral organs. Comprised of 80,000–100,000 fibers in larger mammals, 80% of these neurons traveling in the vagus nerve are sensory. During exercise or physical exertion, heart rate increases, and this increase in resting heart rate is sensed by the afferent fibers traveling in the vagus nerve. Activation of this sensory arc in the brain stem activates motor fibers traveling in the efferent arc that descends to the cardiac sinoatrial node. Arrival of action potentials at the heart prolongs the time to subsequent heartbeats, thereby slowing heart rate. Simple reflexes, as in the regulation of heart rate, are activated when the output of the organ system deviates from a set point.
Within the immune system, sensory and motor nerves, the fundamental components of a simple reflex, were first identified in organs of the reticuloendothelial system more than 50 years ago. The thymus, lymph nodes, liver and spleen are all richly innervated by neurons capable of transmitting information to and from the nervous system in order to regulate the activity of hematopoetic cells during antigen exposure, infection, or sterile injury. Early studies of fever, inflammation, anorexia, and sickness behavior focused on products of inflammatory and immune responses modulating neuronal signals in the brain stem. For example, interleukin-1 (IL-1) was extensively studied as a mediator of fever capable of interacting with specific receptors expressed on neurons in the thermal regulatory centers of the brain stem hypothalamus (4–7). Activation of IL-1 receptor dependent signaling in the brain also mediates the development of anorexia and behavioral withdrawal, termed “sickness syndrome” (8, 9). These and other studies with other cytokine mediators established the dogma that cytokines produced in the peripheral tissues that gain access to the brain, or cytokines that are produced locally in the brain by astrocytes and microglial cells, are capable of mediating sickness behaviors and changing the neurological status of the host. Seminal studies by Linda Watkins soon presented a significant challenge to this simple dogma (10).
The Inflammatory Reflex
In the early 1990’s, when Watkins and her colleagues administered IL-1 to rats via the intraperitoneal route they observed, as expected, the onset of hyperthermia (10, 11). When they repeated these experiments in animals subjected to vagotomy, in which the connections in the vagus nerve to the brain were cut, they found that administration of IL-1 failed to produce a fever. This gave direct evidence that sensory signals traveling in the vagus nerve participates in the onset of the fever response (10). Independent work by Niijima demonstrated that the presence of IL-1 in the liver activates ascending signals in the vagus nerve that are transmitted to the brainstem, then relayed as efferent signals descending in the vagus nerve to the spleen, thymus and other organs (12–14). Together, these findings suggested that cytokines can activate functional afferent neural signals to the brain stem. An independent study and an unexpected experimental result in our laboratory led to the discovery of the inflammatory reflex.
We had developed a cytokine blocking molecule (CNI-1493) (15–18) and were studying its effects in the brain of animals with stroke, when we made the striking observation that production of TNF and other cytokines in the reticuloendothelial system was inhibited by the presence of CNI-1493 in the brain (16). Accordingly, we postulated that signals descending from the brain in the vagus nerve comprise a previously unknown motor arc in an “inflammatory reflex”, completing a sensory arc activated by the presence of IL-1 and other cytokines (19). We repeated the experiments after cutting the vagus nerve, and observed that CNI-1493 in the brain no longer inhibited cytokine production in the reticuloendothelial system (16). The inescapable conclusion from these experiments was that signals descending from the brain stem to the immune system in the vagus nerve regulated cytokine production.
We then began to directly explore the molecular and neurophysiological mechanisms using nerve stimulators positioned on the cervical vagus nerve in anesthetized animals during endotoxemia. The results defined the “inflammatory reflex,” a neural reflex circuit of action potentials traveling in the sensory and motor vagus nerve that regulate cytokine production in the spleen (19–22). The splenic nerve is an adrenergic nerve, producing norepinephrine in the vicinity of lymphocytes in the spleen (23). A discrete subset of lymphocytes regulated by the splenic nerve signals express choline acetyltransferase, the rate-limiting enzyme in the biosynthesis of acetylcholine (23, 24). Acetylcholine released by lymphocytes under the control of adrenergic splenic nerve signals inhibits macrophage cytokine release, and shifts them towards an M2 anti-inflammatory, tissue protective phenotype. Acetylcholine-induced signal transduction in monocytes/macrophages is mediated by alpha-7 nicotinic acetylcholine receptors (25) which inhibits the nuclear translocation of NFkB (26), activates JAK2/STAT3 pathway (27) and stabilizes mitochondrial membranes and downregulates the activity of the inflammasome (28) (Figure 1). The net effect of vagus nerve mediated signals within the spleen is the inhibition of cytokine release by red pulp and marginal zone macrophages, that together normally account for 90% of the TNF and IL-1 produced during acute endotoxemia (23, 29).
Figure 1. Mechanisms by which acetylcholine inhibits cytokine release.
Extracellular acetylcholine (Ach) inhibits cytokine production through nicotinic acetylcholine receptor subunit α7 (α7nAChR), which is expressed by cytokine-producing immune cells. α7nAchR signal transduction results in phosphorylation of CREB, which increases expression of cfos that inhibits NF-κB activity leading to suppression of cytokine production. Interaction of α7nAchR with JAK2 leads to phosphorylation of STAT3. Phosphorylated STAT3 dimers translocate to the nucleus to induce suppression of cytokine production. Activation of immune cells with extracellular ATP leads to rapid influx of acetylcholine into the cytoplasm. Cytoplasmic acetylcholine attenuates mitochondrial DNA release via mitochondrial α7nAchR and subsequently inhibits inflammasome activation.
These mechanistic insights have enabled studies of selective nerve stimulation of the inflammatory reflex to block innate immunity and inflammation in animal models of sepsis, endotoxemia, collagen induced arthritis, hemorrhagic shock, ischemia reperfusion injury, autoimmune myocarditis, ileus, and colitis (30–40). A comprehensive and unabridged review of these studies is beyond the scope of this review, but this body of work enabled the development of a clinical trial for humans with rheumatoid arthritis. As reported quite recently, stimulation of the inflammatory reflex in rheumatoid arthritis patients significantly inhibited cytokine production and provided therapeutic benefit in two cohorts of patients, those resistant to methotrexate therapy, and those resistant to combined therapy with methotrexate and biological inhibitors of cytokines (41). This first in man study validated the experiments from the basic science laboratories and applied these concepts to patients.
What can be learned from the principles of the inflammatory reflex, and how can these be applied to other questions in immunology? In essence, these studies indicate that neurons have a highly conserved role in modulating the development of immunity. By approaching fundamental questions in immunology from the perspective of neuroscience, a wealth of hypotheses become testable. By focusing experimental design around principles of basic reflex circuits it becomes plausible to address the role of immunological mechanisms in activating sensory neurons, in modulating neurological signaling, and in responding to input from motor neurons. As reviewed in brief here, including the neuron as an active participant in the development of innate and adaptive immunity provides new understanding and new opportunities for therapy (Table 1, Figure 2).
Table 1.
Neural reflexes in immunology
Neural Reflex | Experimental model | Activation model | Result | Reference |
---|---|---|---|---|
Inflammatory reflex | Endotoxin-induced shock | Direct electrical stimulation of cervical vagus nerve | Decreased circulating TNF, Attenuation of shock | 23, 25, 29, 31 |
Cecal ligation and puncture | Transcutaneous stimulation of cervical vagus nerve | Decreased circulating HMGB1, Improved survival | 29, 35 | |
Collagen induced arthritis | Direct electrical stimulation of cervical vagus nerve | Improved arthritis incidence | 32, 36 | |
Ileus | Administration of α7-nAChR agonist | Decreased intestinal inflammation | 40, 57 | |
Myocardial infarction | Administration of α7-nAChR agonist | Decreased cardiac myoglobin release during reperfusion injury | 38 | |
Colitis | Administration of α7-nAChR agonist | Decreased colitis severity | 39 | |
Hemorrhagic shock | Direct electrical stimulation of cervical vagus nerve | Decreased hypotension severity and circulating TNF, Improved survival, | 33 | |
Pancreatitis | Administration of α7-nAChR agonist | Decreased pancreatitis severity | 30 | |
Ischemia reperfusion injury | Direct electrical stimulation of cervical vagus nerve | Decreased cytokine production, Attenuation of shock and tissue damage | 37 | |
Neural circuits in antibody responses | Antibody response to bacterial antigen | Direct electrical stimulation of cervical vagus nerve | Impaired migration of B cells, neutrophils, monocytes and dendritic cells, Reduced antigen-specific antibody production | 48 |
Vagus nerve-adrenal reflex | Endotoxin-induced shock | Electrical stimulation of the sciatic nerve | Decreased cytokines release, Attenuation of organ dysfunction | 50, 52 |
Cecal ligation and puncture | Electrical stimulation of the sciatic nerve | Decreased cytokines and improved survival | 51 | |
Paw edema | Laser stimulation of the sciatic nerve | Decreased paw edema and temperature | 55 | |
Collagen induced arthritis | Electrical stimulation of the sciatic nerve | Improved arthritis incidence, Attenuated cytokine levels | 54 | |
Enteric neural reflex | Intestinal peristalsis | Selective depletion of muscularis macrophages, luminal infection | Disturbed peristaltic activity, Reduced neuronal activation | 58, 59 |
Postoperative ileus | Direct electrical stimulation of cervical vagus nerve | Improved intestinal inflammation and postoperative ileus | 57 | |
Sensory axon-axon reflex | Bacterial infection model | Bacterial infection and mechanical, heat and cold hypersensitivity | Bacteria directly activate nociceptors, and immune response is not necessary for bacterial-induced pain | 62 |
Nociceptive reflex in lung | Allergic lung inflmmation | Administration of nociceptor antagonist | Reduced airway inflammation and bronchial hyper responsiveness | 75 |
Gateway reflex | Experimental allergic encephalomyelitis | Tail suspension model | Regulates T-cell recruitment into the central nervous system | 76 |
Neural reflex in cancer | Prostate Cancer | Ablation of adrenergic neurons, Surgical denervation | Attenuated development of tumors in prostate | 77 |
Administration of cholinergic agonists | Enhanced tumor cell invasion and metastasis | 77 | ||
Pharmacological blockade or genetic disruption of the stromal type 1 muscarinic receptor | Improved survival | 77 | ||
Gastric cancer | Surgical denervation of the stomach | Reduced tumor incidence and progression | 80 | |
Lung cancer | Administration of adrenergic antagonist | Reduced metastasis | 81 | |
Ovarian cancer | Restraint stress | Increased tumor growth | 82, 83 | |
Melanoma | Administration of adrenergic antagonist | Decreased tumor growth, increased tumor apoptosis and reduced angiogenesis | 84 |
Figure 2. Neural reflex circuits in immunity.
(A) The inflammatory reflex. The efferent signals generated in the vagus nerve are transmitted via the celiac ganglion to the spleen to acetylcholine-producing (ChAT+) T cells. Acetylcholine (Ach) attenuates cytokine production by macrophages in α7nAChR-dependent manner. (B) Splenic neural circuits modulating antibody production. Activation of vagus nerve culminates into stimulation of the adrenergic splenic nerve resulting in release of norepinephrine (NE) leading to accumulation of CD11+ B cells in the marginal zone and decreased antibody production. (C) The Gateway reflex. Soleus muscle contractions activates afferent neural signals that culminate into efferent adrenergic signals at the lumbar 5 level modulating the expression of CCL20 by the endothelial cells and providing an important control mechanism that gates the entry of pathogenic T cells into the CNS. (D) Neural reflexes in cancer. In a model of prostate cancer, adrenergic nerves promote tumor growth via norepinephrine release and cholinergic nerves within the tumor tissue enhance tumor metastasis by releasing acetylcholine. (E) Nociceptive reflexes in lung. The by-products of allergic inflammatory response activate sensory neurons and immune cells in the lung. IL-5 released by activated immune cells directly activates Nav1.8 positive nociceptors and induces the release of vasoactive peptide VIP. CD4+ T cells and Type 2 innate lymphoid cells respond via a VIP receptor, and produce elevated levels of IL-5, IL-13 and other cytokines that activate IgE production by B cells. VIP signaling and IgE activates and recruits immune cells to amplify the inflammatory responses in the lung. (F) Sensory axon-axon reflex. Bacterial-derived N-formylated peptides or toxins activate sensory neurons resulting in a release of neuropeptides (galanin, substance P, CGRP) that directly suppress innate immune activation. (G) Vagus nerve-adrenal reflex. Activation of the sciatic nerve results in the efferent vagus nerve signals culminating in the adrenal medulla leading to increased production of dopamine that targets dopaminergic type 1 receptors and suppresses systemic inflammation. (H) Enteric neural reflexes. Neuronal adrenergic signals modulate the switch of muscularis macrophages to tissue protective phenotype M2 by signaling through β2 adrenergic receptors. Enteric neurons and muscularis macrophages regulate homeostasis by production of CSF-1 and BMP respectively. Direct electrical stimulation of the vagus nerve results in acetylcholine release by cholinergic myenteric neurons leading to attenuation of inflammation in α7nAChR manner.
Splenic neural circuits modulating antibody production
Lymphocytes and monocytes express alpha-adrenergic (α-ARs) and beta 2-adrenergic receptors (β2AR), and binding of norepinephrine to its receptor modulates cell homing, proliferation, and immune cell function. Catecholamines have been implicated in diverse responses to B cell activation and antibody production. Exposure of naïve B cells to norepinephrine can either increase (42) or decrease (43) Th2 (T helper 2) cell-dependent antibody production. Norepinephrine-mediated modulation of B cell antibody production requires signaling via β-ARs, but not α-ARs (44). Maturity states of B cells further govern the effects of norepinephrine on antibody production: activation of β2AR in early stages of B cell activation may increase the number of antibody-secreting cells or the level of antibody produced by antibody secreting cells, whereas B cell differentiation and function is inhibited by β2AR stimulation in more mature cells (45, 46). Animals lacking β2AR expression have normal lymphoid organ cell number/phenotype/histology, contact sensitivity responses, and T cell-dependent antibody responses as compared to wild type animals. B cells devoid of β2AR fail to respond to norepinephrine, indicating that other adrenergic receptors do not compensate for the absence in β2AR expression (47). Together, these data suggest that in the absence of β2AR, other non-adrenergic mechanisms can maintain immune homeostasis.
Reflex neural networks in lymphoid organs maintain the integrity of antibody responses. During pneumococcal invasion, neutrophils, monocytes and dendritic cells capture and transport the bacteria to the spleen, where resident antigen-specific marginal zone B cells and B1 cells are activated to differentiate into antibody-secreting cells. Marginal zone B cells migrate along splenic nerves, which secrete norepinephrine as the neurotransmitter, arriving at the red pulp venous sinuses where they become antibody-secreting cells, releasing antibodies into the blood (48). Adrenergic splenic neurotransmitter release is enhanced by stimulation of the vagus or splenic nerves, providing a critical regulatory step in splenic B-cell activation and migration that is key to the efficient secretion of antibodies (48).
As noted earlier, the adrenergic splenic nerve also modulates the activity of choline acetyltransferase expressing T cells that produce acetylcholine in spleen, and are necessary to suppress cytokine production by splenic macrophages under the control of the inflammatory reflex (24). Activation of the inflammatory reflex by direct electrical stimulation of the vagus nerve or administration of nicotine arrests neutrophil, dendritic cell and B-cell migration, and decreases antibody secretion. Chemical ablation of the adrenergic splenic nerves decreases antibody titers significantly, indicating that adrenergic signals modulate B cell activation and antibody responses. Importantly, ablation of splenic nerves suppresses the inhibitory effect of nicotine on antigen production, indicating that both cholinergic and adrenergic signals modulate B cell antibody responses. Detailed analysis of the neural regulation of antibody responses indicates that cholinergic stimulation induces accumulation of antigen specific activated B cells in the marginal zone (48). The implications of these results extend well beyond antibody production to other adaptive immune responses, because neural signals also control egress of immune cells from the bone marrow (49).
Vagus nerve-adrenal reflex
Torres-Rosas and colleagues (50) mapped a discreet immunoregulatory neural reflex that utilizes cholinergic and dopaminergic neurons. By subjecting animals to either adrenalectomy, cervical or subdiaphragmatic vagotomy, they mapped a sciatic to vagus neural reflex circuit that regulates inflammatory responses. Electrical stimulation of the sciatic nerve sends sensory signals to the brainstem that un turn activate efferent vagus nerve firing to the adrenal medulla. Vagus nerve mediated activation of the adrenal medulla increased production of dopamine that suppresses systemic inflammation to improve survival in animals with lethal sepsis by signaling through dopaminergic type 1 (D1) receptors (50).
Strikingly similar findings were obtained in other models of inflammatory diseases. Electrical stimulation of the sciatic nerve significantly reduced circulating levels of cytokine in a murine endotoxemia model in a vagus nerve dependent manner. Blocking of vagus nerve activity with either pharmacological antagonists or surgical ablation suppressed the inhibitory effects of electrical stimulation (51–53). In a collagen-induced arthritis model, electrical stimulation of the sciatic nerve significantly reduced arthritis incidence, attenuated inflammatory cytokine levels, and prevented joint destruction (54). More recently, activation of the sciatic nerve using low-power laser therapy significantly reduced localized inflammation in a murine paw edema model (55). The precise route by which the activation of the sciatic nerve transmits the signals to the brainstem is not known, but may involve sensory neurons in the sciatic nerve, the lumbosacral plexus, the vagus nerve, and a terminal dopaminigeric neurotransmitter. It is interesting to consider the therapeutic implications of a sciatic-vagus-neural circuit because it may be possible to stimulate afferent neural responses in the sciatic nerve to induce anti-inflammatory efferent vagus nerve signaling that will suppress subsequent inflammatory responses.
Enteric neural reflexes
Macrophages are anatomically stratified in the layers of the intestinal wall, and play a vital role in maintaining tissue homeostasis through scavenging bacteria and foreign antigens (56). In the gastrointestinal tract, which is continuously exposed to microbial products and dietary antigens, macrophage activation is tightly controlled to prevent chronic inflammation and tissue damage. Three recent studies provide unexpected evidence that enteric neurons reflexively modulate functional phenotypes of the intestinal macrophages under normal physiological conditions and in bacterial infection. In a murine model of postoperative ileus, electrical stimulation of the vagus nerve attenuated inflammation and improved postoperative intestinal transit. Anterograde tracing of vagus nerve to the gut demonstrated a dense network of cholinergic vagus fibers in close proximity to muscularis macrophages. Acetylcholine released by cholinergic myenteric neurons directly modulated inflammatory responses by muscularis macrophages, and activation of alpha 7 nicotinic receptors suppressed inflammatory responses in the muscle layer (57). Enteric neurons regulate homeostasis of muscularis macrophages through the production of colony stimulating factor-1, a growth factor necessary for macrophage survival (58). Muscularis macrophages, in turn, secrete bone morphogenetic protein (BMP)-2, which activates the BMP receptor (BMPR) expressed by enteric neurons. BMPR-mediated activation of enteric neurons is essential for maintaining proper tissue function. Selective ablation of the muscularis macrophage population is correlated with reduced neuronal activation of SMAD1, SMAD5 and SMAD8, the downstream signaling mediators of BMP receptors, resulting in impaired contractility. Interestingly, antibiotic-treated mice expressed significantly less Bmp2 as compared to control; indicating that luminal microbiota regulate the neuronal interaction with macrophages.
Recent studies identified a novel reflex mechanism in the gut activated by the gut microbiome that forces macrophages into a tissue protective phenotype (59). Intestinal resident macrophages exhibit distinct cell dynamics, morphological features and functional phenotypes depending on their proximity to the gut lumen. Lamina propria macrophages reside closer to the gut mucosa, and preferentially express a proinflammatory M1 phenotype. In contrast, muscularis macrophages are located more distal from luminal surface in the submucosal region between the circular and longitudinal muscle layers, and primarily express a M2 tissue protective gene profile. Muscularis macrophages share a niche with a dense network of neurons. Luminal bacterial infection results in activation of extrinsic adrenergic neurons innervating the intestine. Norepinephrine released by these neurons in turn activates development of a tissue protective phenotype in muscularis macrophages by signaling through β2 adrenergic receptors. Earlier studies using electron microscopy and immune staining have suggested that muscularis macrophages form direct synapses with enteric neurons (60, 61). Thus, the bacterial antigen mediated tissue protective program in muscularis macrophages is regulated by adrenergic neural circuits.
Sensory axon-axon reflex
Bacterial-derived N-formylated peptides or toxins interact with receptors expressed on nociceptor neurons (62). Immune cell activation is not necessary for bacteria-induced hyperalgesia during infection. Moreover, direct binding of bacterial products to nociceptor neurons induces an axonal-axonal reflex mechanism that modulates innate immune responses. Activated nociceptor neurons release neuropeptides, including galanin, somatostatin and calcitonin gene-related peptide (CGRP) that directly suppress innate immune activation in the region of infection (62). Accordingly, ablation of nociceptor neurons increases immune cell influx and lymphadenopathy. It is plausible that pathogenic bacteria utilize this neural mechanism to enhance virulence. Gram-negative bacteria induce hyperalgesia by directly activating TRPA1 expressing nociceptors. Lipopolysaccharide (LPS), a cell wall component of gram-negative bacteria, activates and depolarizes TRPA1 expressing nociceptors in a TLR4-independent manner, and induces hyperalgesia (63). LPS-induced hyperalgesia may also play a major role in chronic pain and neuropathy observed in diabetic patients. Pattern recognition receptors, including TLR4 and CD14, which are normally expressed on immune cells, are also expressed on sensory neurons (64–66). Lipopolysaccharide binds directly to sensory neurons in a TLR4 dependent manner, and induces production of nociceptin (67), an opioid-related peptide that is upregulated during inflammation and associated with hyperalgesia (67–69). LPS binding also triggers activation of sensory neurons to enhance production of the vasodilator CGRP from dorsal root ganglion (70, 71). Together, these studies suggest that direct activation of nociceptors by bacterial products participate in the molecular mechanisms of pain and stimulate reflex regulation of innate immunity.
Nociceptive reflexes in lung
The lung is innervated by a rich network of sensory neurons that express nociceptive receptors (72–74). Activation of nociceptors enhances the release of neuropeptides, including CGRP and substance P. These mediators increase vascular permeability and vasodilation, and activate innate and adaptive immune cells. Recent evidence indicates that by-products of allergic inflammatory response activate lung nociceptors to modulate allergic lung inflammatory responses (75). Specifically, IL-5 released by activated immune cells induces the release of vasoactive peptide VIP by Nav1.8 positive nociceptors. VIP in turn activates CD4+ T cells and Type 2 innate lymphoid cells in a VIP receptor (VPAC2) dependent manner to produce elevated levels of IL-5, IL-13 and other cytokines. VIP signaling through VPAC2 activates and recruits immune cells to amplify the inflammatory responses in the lung. Silencing of nociceptors by either genetic ablation or chemical blocking significantly inhibits cytokine production, and increases resolution of allergic lung inflammation. These studies delineate neural circuits that drive a feed-forward amplification loop to exacerbate allergic lung inflammation opening new avenues for developing therapeutic strategies.
A gateway reflex
The blood brain barrier strictly limits the flow of proteins and cells from the blood stream to the central nervous system (CNS). In a mouse model of multiple sclerosis, Arima and colleagues (76) identified a specific neural circuit that modulates trafficking of pathogenic T cells into the CNS. In this adoptive transfer model of experimental allergic encephalomyelitis, myelinated nerve specific T cells were introduced into naïve recipient mice to maintain CNS quiescence. At the earliest phase, autoreactive T cells preferentially accumulated at specific sites in the spinal cord near the fifth lumbar level, rather than in the brain or at other levels of the spinal cord. In an attempt to elucidate the mechanism for this specificity of the “entry gateway”, they discovered that the expression of CCL20, a chemokine important for T cell accumulation, is increased in the dorsal blood vessels of the fifth lumbar cord. As the fifth lumbar vertebrae lies close to the dorsal root ganglia of sensory neurons that innervate the soleus and other leg muscles, they reasoned that weight bearing stimulation of the soleus muscles might contribute to the sensory nerve activation resulting in induction of high CCL20 expression in the blood vessels of the fifth lumbar cord. They studied this possibility by silencing the muscle sensitive neuronal pathway by suspending mice from their tail, so that forelimbs, and not the hind limbs, were subjected to weight bearing. This significantly decreased CCL20 expression and suppressed pathogenic T cell accumulation in the fifth lumbar cord level. Instead, these pathogenic T cells accumulated at the cervical cord, indicating that stimulation of the forelimbs opened a new gateway for the pathogenic cells. Moreover, pharmacological inhibition of adrenergic receptors significantly suppressed accumulation of pathogenic T cells, and improved clinical signs of the disease. Together, these studies reveal a reflex circuit that controls a critical step in the initiation and progression of autoimmune disease by regulating blood brain barrier permeability to pathogenic T cells.
Neural reflexes in cancer
Neural circuits play a critical role in both the development and spread of tumors. In an experimental model of prostate cancer, adrenergic nerves promote tumor growth by producing norepinephrine, which binds to and stimulates adrenergic receptors (β2 and β3) on the stromal cells in the tumor microenvironment. In addition, cholinergic nerves within the tumor tissue enhance tumor metastasis by releasing acetylcholine, which activates the stromal type 1 muscarinic receptor, and enhances prostate cancer metastasis to distant lymph nodes (77). Recent observations in patients with prostate cancer support the preclinical data, and strongly suggest that neural circuits are critical for tumor development and metastasis (77). Higher neuronal density is observed within tumors and in normal prostate tissue surrounding tumors in patients with aggressive prostate cancers as compared to patients who had less aggressive tumors. Specifically, normal prostate tissue surrounding the tumor is densely innervated with TH+ adrenergic fibers, whereas VAChT+ cholinergic fibers are restricted inside the tumor. High neural densities of adrenergic fibers are associated with a higher tumor proliferative index, shorter recurrence time, and tumor metastasis, whereas cholinergic fiber density is significantly associated with extra-prostatic extension. These observations correlate with the epidemiological data showing that beta-blockers, which lower blood pressure by blocking β-adrenergic receptors, is associated with improved survival in prostate cancer (78, 79).
Neural reflex circuits have also been implicated in development and progression of other cancers. Denervation of the stomach markedly reduced tumor incidence and progression in preclinical models of gastric cancer (80). In rodent models of melanoma, lung cancer and ovarian cancer, sustained adrenergic activation promotes cancer growth and metastasis (81–84). In addition to their effect on tumor cells, norepinephrine and epinephrine also stimulate endothelial cells, fibroblasts and modulate functions of immune cells, leaving open a broader potential impact of neurotransmitters on the tumor microenvironment (85). Several retrospective clinical studies have revealed that beta-blockers may have antitumor activity, reducing metastasis, tumor recurrence, cancer-specific mortality and increasing survival time for patients with melanoma, breast cancer, lung cancer, ovarian cancer and prostate cancer (78, 86–90).
Conclusions
The discovery that neurons operating reflexively are functional components of the immune system represents a fundamentally new insight into understanding of immunity. Cells of hematopoetic origin share the frontline of host defense with neurons. Monocytes and neurons both detect changes in the environment. Macrophages can respond by producing cytokines and other mediators, and neurons respond by producing action potentials. Neurons and macrophages indeed share the responsibility for mobilizing host responses to infection and injury, and share responsibilities for producing a coordinated and balanced immune response. Highly conserved neural circuits act reflexively to maintain homeostasis during the development of immunity, and inflammation. This discovery has raised many more questions that future students of immunology will likely approach, expanding their research focus from cells of hematopoetic origin to include neurons. These new studies of immunology that exploit essentials from neuroscience will continue to enlighten our understanding of basic principles governing immunity.
Acknowledgments
This work was supported by the grant from the National Institute of General Medical Sciences, National Institutes of Health: 1R35 GM118182-01 (KJT)
References
- 1.Burke RE. Sir Charles Sherrington’s the integrative action of the nervous system: A centenary appreciation. Brain. 2007;130:887–894. doi: 10.1093/brain/awm022. [DOI] [PubMed] [Google Scholar]
- 2.Pearce JMS. Sir Charles Scott Sherrington (1857–1952) and the synapse. J Neurol Neurosurg Psychiatry. 2004;75:544. [PMC free article] [PubMed] [Google Scholar]
- 3.Styer KL, Singh V, Macosko E, Steele SE, Bargmann CI, Aballay A. Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR. Science. 2008;322:460–4. doi: 10.1126/science.1163673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lesnikov VA, Efremov OM, Korneva EA, Van Damme J, Billiau A. Fever produced by intrahypothalamic injection of interleukin-1 and interleukin-6. Cytokine. 1991;3:195–198. doi: 10.1016/1043-4666(91)90016-7. [DOI] [PubMed] [Google Scholar]
- 5.Dinarello Ca. Cytokines as endogenous pyrogens. J Infect Dis. 1999;179(Suppl):S294–S304. doi: 10.1086/513856. [DOI] [PubMed] [Google Scholar]
- 6.Malinowsky D, Chai Z, Bristulf J, Simoncsits A, Bartfai T. The type I interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands. Neurosci Lett. 1995;201:33–36. doi: 10.1016/0304-3940(95)12123-l. [DOI] [PubMed] [Google Scholar]
- 7.Zetterström M, Lundkvist J, Malinowsky D, Eriksson G, Bartfai T. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFκB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein. Eur Cytokine Netw. 1998;9:131–138. [PubMed] [Google Scholar]
- 8.Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, Maier SF, Watkins LR. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: A possible mechanism for immune-to-brain communication. Brain Res Bull. 1997;43:357–364. doi: 10.1016/s0361-9230(97)00020-8. [DOI] [PubMed] [Google Scholar]
- 9.Goehler LE, Gaykema RPA, Hansen MK, Anderson K, Maier SF, Watkins LR. Vagal immune-to-brain communication: A visceral chemosensory pathway. Autonomic Neuroscience: Basic and Clinical. 2000;85:49–59. doi: 10.1016/S1566-0702(00)00219-8. [DOI] [PubMed] [Google Scholar]
- 10.Watkins LR, Goehler LE, Relton JK, Tartaglia N, Silbert L, Martin D, Maier SF. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett. 1995;183:27–31. doi: 10.1016/0304-3940(94)11105-r. [DOI] [PubMed] [Google Scholar]
- 11.Milligan ED, McGorry MM, Fleshner M, Gaykema RPA, Goehler LE, Watkins LR, Maier SF. Subdiaphragmatic vagotomy does not prevent fever following intracerebroventricular prostaglandin E2: Further evidence for the importance of vagal afferents in immune-to-brain communication. Brain Res. 1997;766:240–243. doi: 10.1016/s0006-8993(97)00705-1. [DOI] [PubMed] [Google Scholar]
- 12.Niijima A, Hori T, Aou S, Oomura Y. The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J Auton Nerv Syst. 1991;36:183–192. doi: 10.1016/0165-1838(91)90042-2. [DOI] [PubMed] [Google Scholar]
- 13.Niijima A, Hori T, Katafuchi T, Ichijo T. The effect of interleukin-1β on the efferent activity of the vagus nerve to the thymus. J Auton Nerv Syst. 1995;54:137–144. doi: 10.1016/0165-1838(95)00003-g. [DOI] [PubMed] [Google Scholar]
- 14.Niijima A. The afferent discharges from sensors for interleukin 1β in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst. 1996;61:287–291. doi: 10.1016/s0165-1838(96)00098-7. [DOI] [PubMed] [Google Scholar]
- 15.Borovikova LV, Ivanova S, Nardi D, Zhang M, Yang H, Ombrellino M, Tracey KJ. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Autonomic Neuroscience: Basic and Clinical. 2000;85:141–147. doi: 10.1016/S1566-0702(00)00233-2. [DOI] [PubMed] [Google Scholar]
- 16.Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM, Tracey KJ. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med. 2002;195:781–8. doi: 10.1084/jem.20011714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cohen PS, Nakshatri H, Dennis J, Caragine T, Bianchi M, Cerami A, Tracey KJ. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci U S A. 1996;93:3967–71. doi: 10.1073/pnas.93.9.3967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Granert C, Abdalla H, Lindquist L, Diab A, Bahkiet M, Tracey KJ, Andersson J. Suppression of macrophage activation with CNI-1493 increases survival in infant rats with systemic Haemophilus influenzae infection. Infect Immun. 2000;68:5329–34. doi: 10.1128/iai.68.9.5329-5334.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tracey KJ. The inflammatory reflex. Nature. 2002;420:853–9. doi: 10.1038/nature01321. [DOI] [PubMed] [Google Scholar]
- 20.Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2009;9:418–28. doi: 10.1038/nri2566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Andersson U, Tracey KJ. Reflex principles of immunological homeostasis. Annu Rev Immunol. 2012;30:313–335. doi: 10.1146/annurev-immunol-020711-075015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Oke SL, Tracey KJ. From CNI-1493 to the immunological homunculus: physiology of the inflammatory reflex. J Leukoc Biol. 2008;83:512–7. doi: 10.1189/jlb.0607363. [DOI] [PubMed] [Google Scholar]
- 23.Rosas-Ballina M, Ochani M, Parrish WR, Ochani K, Harris YT, Huston JM, Chavan S, Tracey KJ. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A. 2008;105:11008–11013. doi: 10.1073/pnas.0803237105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rosas-Ballina M, Olofsson PS, Ochani M, Valdés-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011;334:98–101. doi: 10.1126/science.1209985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384–8. doi: 10.1038/nature01339. [DOI] [PubMed] [Google Scholar]
- 26.Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10:1216–1221. doi: 10.1038/nm1124. [DOI] [PubMed] [Google Scholar]
- 27.de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6:844–851. doi: 10.1038/ni1229. [DOI] [PubMed] [Google Scholar]
- 28.Lu B, Kwan K, Levine YA, Olofsson PS, Yang H, Li J, Joshi S, Wang H, Andersson U, Chavan SS, Tracey KJ. α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol Med. 2014;20:350–8. doi: 10.2119/molmed.2013.00117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med. 2006;203:1623–8. doi: 10.1084/jem.20052362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, van der Poll T. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 2006;130:1822–30. doi: 10.1053/j.gastro.2006.02.022. [DOI] [PubMed] [Google Scholar]
- 31.Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458–62. doi: 10.1038/35013070. [DOI] [PubMed] [Google Scholar]
- 32.Levine YA, Koopman FA, Faltys M, Caravaca A, Bendele A, Zitnik R, Vervoordeldonk MJ, Tak PP. Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Ameliorates Disease in Rat Collagen-Induced Arthritis. PLoS One. 2014;9:e104530. doi: 10.1371/journal.pone.0104530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Guarini S, Altavilla D, Cainazzo MM, Giuliani D, Bigiani A, Marini H, Squadrito G, Minutoli L, Bertolini A, Marini R, Adamo EB, Venuti FS, Squadrito F. Efferent vagal fibre stimulation blunts nuclear factor-kB activation and protects against hypovolemic hemorrhagic shock. Circulation. 2003;107:1189–1194. doi: 10.1161/01.cir.0000050627.90734.ed. [DOI] [PubMed] [Google Scholar]
- 34.van Maanen MA, Stoof SP, van der Zanden EP, de Jonge WJ, Janssen RA, Fischer DF, Vandeghinste N, Brys R, Vervoordeldonk MJ, Tak PP. The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum. 2009;60:1272–81. doi: 10.1002/art.24470. [DOI] [PubMed] [Google Scholar]
- 35.van Westerloo DJ, Giebelen IAJ, Florquin S, Daalhuisen J, Bruno MJ, de Vos AF, Tracey KJ, van der Poll T. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis. 2005;191:2138–48. doi: 10.1086/430323. [DOI] [PubMed] [Google Scholar]
- 36.van Maanen Ma, Vervoordeldonk MJ, Tak PP. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol. 2009;5:229–32. doi: 10.1038/nrrheum.2009.31. [DOI] [PubMed] [Google Scholar]
- 37.Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, Tracey KJ. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg. 2002;36:1231–6. doi: 10.1067/mva.2002.129643. [DOI] [PubMed] [Google Scholar]
- 38.Leib C, Göser S, Lüthje D, Öttl R, Tretter T, Lasitschka F, Zittrich S, Pfitzer G, Katus HA, Kaya Z. Role of the cholinergic antiinflammatory pathway in murine autoimmune myocarditis. Circ Res. 2011;109:130–140. doi: 10.1161/CIRCRESAHA.111.245563. [DOI] [PubMed] [Google Scholar]
- 39.Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology. 2006;131:1122–30. doi: 10.1053/j.gastro.2006.08.016. [DOI] [PubMed] [Google Scholar]
- 40.Lubbers T, Buurman W, Luyer M. Controlling postoperative ileus by vagal activation. World J Gastroenterol. 2010;16:1683–7. doi: 10.3748/wjg.v16.i14.1683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR, Mehta AD, Levine YA, Faltys M, Zitnik R, Tracey KJ, Tak PP. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113:8284–9. doi: 10.1073/pnas.1605635113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kohm AP, Sanders VM. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol. 1999;162:5299–308. [PubMed] [Google Scholar]
- 43.Kruszewska B, Felten SY, Moynihan JA. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J Immunol. 1995;155:4613–20. [PubMed] [Google Scholar]
- 44.Kouassi E, Li YS, Boukhris W, Millet I, Revillard JP. Opposite effects of the catecholamines dopamine and norepinephrine on murine polyclonal B-cell activation. Immunopharmacology. 1988;16:125–37. doi: 10.1016/0162-3109(88)90001-x. [DOI] [PubMed] [Google Scholar]
- 45.Sanders VM, Munson AE. Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody response in vitro. J Pharmacol Exp Ther. 1984;231:527–531. [PubMed] [Google Scholar]
- 46.Sanders VM, Munson AE. Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J Pharmacol Exp Ther. 1984;230:183–92. [PubMed] [Google Scholar]
- 47.Sanders VM, Kasprowicz DJ, Swanson-Mungerson MA, Podojil JR, Kohm AP. Adaptive immunity in mice lacking the β2-adrenergic receptor. Brain Behav Immun. 2003;17:55–67. doi: 10.1016/s0889-1591(02)00056-9. [DOI] [PubMed] [Google Scholar]
- 48.Mina-Osorio P, Rosas-Ballina M, Valdes-Ferrer SI, Al-Abed Y, Tracey KJ, Diamond B. Neural signaling in the spleen controls B-cell responses to blood-borne antigen. Mol Med. 2012;18:618–27. doi: 10.2119/molmed.2012.00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS. Signals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone Marrow. Cell. 2006;124:407–421. doi: 10.1016/j.cell.2005.10.041. [DOI] [PubMed] [Google Scholar]
- 50.Torres-Rosas R, Yehia G, Peña G, Mishra P, Del Rocio Thompson-Bonilla M, Moreno-Eutimio MA, Arriaga-Pizano LA, Isibasi A, Ulloa L. Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med. 2014;20:291–5. doi: 10.1038/nm.3479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Villegas-Bastida A, Torres-Rosas R, Arriaga-Pizano LA, Flores-Estrada J, Gustavo-Acosta A, Moreno-Eutimio MA. Electrical Stimulation at the ST36 Acupoint Protects against Sepsis Lethality and Reduces Serum TNF Levels through Vagus Nerve- and Catecholamine-Dependent Mechanisms. Evid Based Complement Alternat Med. 2014;2014:451674. doi: 10.1155/2014/451674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Song Q, Hu S, Wang H, Lv Y, Shi X, Sheng Z, Sheng W. Electroacupuncturing at Zusanli point (ST36) attenuates pro-inflammatory cytokine release and organ dysfunction by activating cholinergic anti-inflammatory pathway in rat with endotoxin challenge. Afr J Tradit Complement Altern Med. 2014;11:469–74. doi: 10.4314/ajtcam.v11i2.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Lim HD, Kim MH, Lee CY, Namgung U. Anti-Inflammatory Effects of Acupuncture Stimulation via the Vagus Nerve. PLoS One. 2016;11:e0151882. doi: 10.1371/journal.pone.0151882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Yim YK, Lee H, Hong KE, Il Kim Y, Lee BR, Son CG, Kim JE. Electro-acupuncture at acupoint ST36 reduces inflammation and regulates immune activity in collagen-induced arthritic mice. Evidence-based Complement Altern Med. 2007;4:51–57. doi: 10.1093/ecam/nel054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Erthal V, Nohama P, Werner MFDP, Baggio CH. The Anti-inflammatory Effects of Laser Acupuncture at ST36 (Zusanli) Acupoint in the Model of Acute Inflammation Induced by Carrageenan in the Paw of Mice. Lasers Med Sci. 2014;36:30–33. [Google Scholar]
- 56.Mikkelsen HB, Rumessen JJ. Characterization of macrophage-like cells in the external layers of human small and large intestine. Cell Tissue Res. 1992;270:273–9. doi: 10.1007/BF00328013. [DOI] [PubMed] [Google Scholar]
- 57.Matteoli G, Gomez-Pinilla PJ, Nemethova A, Di Giovangiulio M, Cailotto C, van Bree SH, Michel K, Tracey KJ, Schemann M, Boesmans W, Vanden Berghe P, Boeckxstaens GE. A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut. 2014;63:938–48. doi: 10.1136/gutjnl-2013-304676. [DOI] [PubMed] [Google Scholar]
- 58.Muller PA, Koscsó B, Rajani GM, Stevanovic K, Berres ML, Hashimoto D, Mortha A, Leboeuf M, Li XM, Mucida D, Stanley ER, Dahan S, Margolis KG, Gershon MD, Merad M, Bogunovic M. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell. 2014;158:300–313. doi: 10.1016/j.cell.2014.04.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Gabanyi I, Muller PA, Feighery L, Oliveira TY, Costa-Pinto FA, Mucida D. Neuro-immune Interactions Drive Tissue Programming in Intestinal Macrophages. Cell. 2016;164:378–391. doi: 10.1016/j.cell.2015.12.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Kinoshita K, Horiguchi K, Fujisawa M, Kobirumaki F, Yamato S, Hori M, Ozaki H. Possible involvement of muscularis resident macrophages in impairment of interstitial cells of Cajal and myenteric nerve systems in rat models of TNBS-induced colitis. Histochem Cell Biol. 2007;127:41–53. doi: 10.1007/s00418-006-0223-0. [DOI] [PubMed] [Google Scholar]
- 61.Phillips RJ, Powley TL. Macrophages Associated with the Intrinsic and Extrinsic Autonomic Innervation of the Rat Gastrointestinal Tract. Auton Neurosci. 2012;169:12–27. doi: 10.1016/j.autneu.2012.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Chiu IM, Heesters BA, Ghasemlou N, Von Hehn CA, Zhao F, Tran J, Wainger B, Strominger A, Muralidharan S, Horswill AR, Bubeck Wardenburg J, Hwang SW, Carroll MC, Woolf CJ. Bacteria activate sensory neurons that modulate pain and inflammation. Nature. 2013;501:52–7. doi: 10.1038/nature12479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Meseguer V, Alpizar Ya, Luis E, Tajada S, Denlinger B, Fajardo O, Manenschijn J-A, Fernández-Peña C, Talavera A, Kichko T, Navia B, Sánchez A, Señarís R, Reeh P, Pérez-García MT, López-López JR, Voets T, Belmonte C, Talavera K, Viana F. TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. Nat Commun. 2014;5:3125. doi: 10.1038/ncomms4125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Wadachi R, Hargreaves KMM. Trigeminal Nociceptors Express TLR-4 and CD14: a Mechanism for Pain due to Infection. J Dent Res. 2006;85:49–53. doi: 10.1177/154405910608500108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Liu T, Gao YJ, Ji RR. Emerging role of Toll-like receptors in the control of pain and itch. Neurosci Bull. 2012;28:131–144. doi: 10.1007/s12264-012-1219-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Diogenes A, Ferraz CCR, Akopian AN, Henry Ma, Hargreaves KM. LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J Dent Res. 2011;90:759–64. doi: 10.1177/0022034511400225. [DOI] [PubMed] [Google Scholar]
- 67.Acosta C, Davies A. Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons. J Neurosci Res. 2008;86:1077–86. doi: 10.1002/jnr.21565. [DOI] [PubMed] [Google Scholar]
- 68.Inoue M, Shimohira I, Yoshida A, Zimmer A, Takeshima H, Sakurada T, Ueda H. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord. J Pharmacol Exp Ther. 1999;291:308–13. [PubMed] [Google Scholar]
- 69.Inoue M, Kobayashi M, Kozaki S, Zimmer A, Ueda H. Nociceptin͞orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. Pharmacology. 1998;95:10949–10953. doi: 10.1073/pnas.95.18.10949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Hou L, Wang X. PKC and PKA, but not PKG mediate LPS-induced CGRP release and [Ca(2+)](i) elevation in DRG neurons of neonatal rats. J Neurosci Res. 2001;66:592–600. doi: 10.1002/jnr.1249. [DOI] [PubMed] [Google Scholar]
- 71.Xing L, Hou L, Wang X. Comparison of calcitonin gene-related peptide release from rat lymphocytes and dorsal root ganglia neurons. Brain Behav Immun. 2002;16:17–32. doi: 10.1006/brbi.2000.0601. [DOI] [PubMed] [Google Scholar]
- 72.Kollarik M, Ru F, Brozmanova M. Vagal afferent nerves with the properties of nociceptors. Auton Neurosci Basic Clin. 2010;153:12–20. doi: 10.1016/j.autneu.2009.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ni D, Gu Q, Hu HZ, Gao N, Zhu MX, Lee LY. Thermal sensitivity of isolated vagal pulmonary sensory neurons: role of transient receptor potential vanilloid receptors. Am J Physiol Regul Integr Comp Physiol. 2006;291:R541–50. doi: 10.1152/ajpregu.00016.2006. [DOI] [PubMed] [Google Scholar]
- 74.Ambrogio GS. Nervous Receptors of the Tracheobronchial Tree. Annu Rev Physiol. 1987;49:611–627. doi: 10.1146/annurev.ph.49.030187.003143. [DOI] [PubMed] [Google Scholar]
- 75.Talbot S, Abdulnour REE, Burkett PR, Lee S, Cronin SJF, Pascal MA, Laedermann C, Foster SL, Tran JV, Lai N, Chiu IM, Ghasemlou N, DiBiase M, Roberson D, Von Hehn C, Agac B, Haworth O, Seki H, Penninger JM, Kuchroo VK, Bean BP, Levy BD, Woolf CJ. Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation. Neuron. 2015;87:341–354. doi: 10.1016/j.neuron.2015.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Arima Y, Harada M, Kamimura D, Park J-H, Kawano F, Yull FE, Kawamoto T, Iwakura Y, K Betz UA, Márquez G, Blackwell TS, Ohira Y, Hirano T, Murakami M. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell. 2012;148:447–57. doi: 10.1016/j.cell.2012.01.022. [DOI] [PubMed] [Google Scholar]
- 77.Magnon C, Hall S, Lin J, Xue X, Gerber L, Freedland S, Frenette P. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341:1–10. doi: 10.1126/science.1236361. 80- [DOI] [PubMed] [Google Scholar]
- 78.G HH, F MW, F SD. Association between use of beta-blockers and prostate cancer-specific survival: A cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. 2014;65:635–641. doi: 10.1016/j.eururo.2013.01.007. [DOI] [PubMed] [Google Scholar]
- 79.Grytli HH, Fagerland MW, Fossa SD, Tasken KA, Haheim LL. Use of beta-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate. 2013;73:250–260. doi: 10.1002/pros.22564. [DOI] [PubMed] [Google Scholar]
- 80.Zhao C, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, Flatberg A, Johannessen H, Friedman RA, Renz BW, Sandvik AK, Beisvag V, Tomita H, Hara A, Quante M, Li Z, Gershon MD, Kaneko K, Fox JG, Wang TC, Chen D. Denervation suppresses gastric tumorigenesis. Sci Transl Med. 2014;6:1–12. doi: 10.1126/scitranslmed.3009569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Melamed R, Rosenne E, Shakhar K, Schwartz Y, Abudarham N, Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a β-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun. 2005;19:114–126. doi: 10.1016/j.bbi.2004.07.004. [DOI] [PubMed] [Google Scholar]
- 82.Nagaraja AS, Dorniak PL, Sadaoui NC, Kang Y, Lin T, Armaiz-Pena G, Wu SY, Rupaimoole R, Allen JK, Gharpure KM, Pradeep S, Zand B, Previs RA, Hansen JM, Ivan C, Rodriguez-Aguayo C, Yang P, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis. Oncogene. 2016;35:2390–2397. doi: 10.1038/onc.2015.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Thaker PH, Han LY, Kamat Aa, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson Ja, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, a Newman R, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12:939–44. doi: 10.1038/nm1447. [DOI] [PubMed] [Google Scholar]
- 84.Dal Monte M, Casini G, Filippi L, Nicchia GP, Svelto M, Bagnoli P. Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization. J Mol Med. 2013;91:1407–1419. doi: 10.1007/s00109-013-1073-6. [DOI] [PubMed] [Google Scholar]
- 85.Li ZJ, Cho CH. Neurotransmitters, more than meets the eye – Neurotransmitters and their perspectives in cancer development and therapy. Eur J Pharmacol. 2011;667:17–22. doi: 10.1016/j.ejphar.2011.05.077. [DOI] [PubMed] [Google Scholar]
- 86.Lemeshow S, Sørensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, Lesinski GB, Jackson R, Glaser R. β-blockers and survival among danish patients with malignant melanoma: A population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2011;20:2273–2279. doi: 10.1158/1055-9965.EPI-11-0249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Melhem-Bertrandt A, Chavez-MacGregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD, Hortobagyi GN, Gonzalez-Angulo AM. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol. 2011;29:2645–2652. doi: 10.1200/JCO.2010.33.4441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Wang HM, Liao ZX, Komaki R, Welsh JW, O’reilly MS, Chang JY, Zhuang Y, Levy LB, Lu C, Gomez DR. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol. 2013;24:1312–1319. doi: 10.1093/annonc/mds616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Diaz ES, Karlan BY, Li AJ. Impact of beta blockers on epithelial ovarian cancer survival. Gynecol Oncol. 2012;127:375–378. doi: 10.1016/j.ygyno.2012.07.102. [DOI] [PubMed] [Google Scholar]
- 90.Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015;121:3444–3451. doi: 10.1002/cncr.29392. [DOI] [PMC free article] [PubMed] [Google Scholar]